Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|June 9, 2001
Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonistsS A Stoch, R A Parker, L Chen, et al.Current Oncology (Toronto, Ont.)|June 20, 2015
Doctor, what are my options? A prospective cohort study of an individualized care plan for patients with gastrointestinal cancerA E Hird, M Lemke, M Turovsky, et al.Current Oncology (Toronto, Ont.)|December 31, 2020
A systematic review and network meta-analysis of second-line therapy in hepatocellular carcinomaS Delos Santos, S Udayakumar, A Nguyen, et al.Cancer Research|June 11, 1999
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonistM E Taplin, G J Bubley, Y J Ko, et al.Current Oncology (Toronto, Ont.)|April 6, 2013
Cost-effectiveness of systemic therapies for metastatic pancreatic cancerV C Tam, Y J Ko, N Mittmann, et al.International Journal of Laboratory Hematology|January 5, 2013
Establishment of reference interval for immature platelet fractionY J Ko, H Kim, M Hur, et al.Current Oncology (Toronto, Ont.)|November 12, 2019
Cost-effectiveness analysis of selective first-line use of biologics for unresectable RAS wild-type left-sided metastatic colorectal cancerW W L Wong, M Zargar, S R Berry, et al.Current Oncology (Toronto, Ont.)|May 3, 2019
What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer?Y J Ko, M Abdelsalam, P Kavan, et al.RSC Advances|May 6, 2022
Strong correlation between flux pinning and epitaxial strain in the GdBa2Cu3O7- /La0.7Sr0.3MnO3 nanocrystalline heterostructureJ Y Oh, C Y Song, Y J Ko, et al.Public Health|March 12, 2014
Effects of employment and education on preterm and full-term infant mortality in KoreaY-J Ko, S-H Shin, S M Park, et al.Pageof 5